Literature DB >> 4642908

Quantitative dinitrochlorobenzene contact sensitization in a normal population.

W J Catalona, P T Taylor, P B Chretien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4642908      PMCID: PMC1553595     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  24 in total

1.  Impaired delayed hypersensitivity in an aging population. Association with antinuclear reactivity and rheumatoid factor.

Authors:  D S Waldorf; R F Willkens; J L Decker
Journal:  JAMA       Date:  1968-03-04       Impact factor: 56.272

2.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

3.  Immunologic alterations in bronchogenic cancer. Sequential study.

Authors:  M J Krant; G Manskopf; C S Brandrup; M A Madoff
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

4.  Delayed hypersensitivity in primary biliary cirrhosis.

Authors:  R A Fox; P J Scheuer; S Sherlock; O Sharma; D G James
Journal:  Gut       Date:  1968-12       Impact factor: 23.059

5.  Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis.

Authors:  J G Walker; M F Greaves
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

6.  Suppression of the tuberculin response in malignant disease.

Authors:  L E Hughes; W D Mackay
Journal:  Br Med J       Date:  1965-12-04

7.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

8.  Immunologic responses in cancer patients.

Authors:  A C Solowey; F T Rapaport
Journal:  Surg Gynecol Obstet       Date:  1965-10

9.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

10.  Development of sensitivity oto dinitrochlorobenzene in patients with sarcoidosis.

Authors:  J V Jones
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

View more
  9 in total

1.  Secondary immunodeficiency in miliary tuberculosis.

Authors:  S Uberoi; A N Malaviya; C Chattopadhyay; R Kumar
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

2.  Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.

Authors:  W J Catalona; J L Tarpley; C Potvin; P B Chretien
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

3.  Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.

Authors:  K Froebel; R D Sturrock; W C Dick; R N MacSween
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

4.  Specific blastogenesis and lymphokine production in DNCB-sensitive human leucocyte cultures stimulated with soluble and particulate DNP-containing antigens.

Authors:  W R Levis; J J Whalen; J A Powell
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

5.  Dinitrochlorobenzene contact sensitization in pulmonary tuberculosis.

Authors:  A N Malaviya; K L Sehgal; R Kumar; H B Dingley
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

6.  Reactive lymphoid cells ('Immunoblasts') in autoimmune and haematological disorders.

Authors:  P A Bacon; R L Sewell; D Crowther
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

7.  [Age dependence of immunological methods for detecting an immunodeficiency state (author's transl)].

Authors:  P A Bürkle; E Tönnesmann; B Schäfer; K Federlin
Journal:  Klin Wochenschr       Date:  1978-08-15

8.  Partial suppression of cell mediated immunity in chromoblastomycosis.

Authors:  J Fuchs; S Pecher
Journal:  Mycopathologia       Date:  1992-08       Impact factor: 2.574

9.  Nutritional status and general immune competence in patients with head and neck cancer.

Authors:  G B Brookes; P Clifford
Journal:  J R Soc Med       Date:  1981-02       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.